Page last updated: 2024-11-05

ici 204,219 and Blood Clot

ici 204,219 has been researched along with Blood Clot in 1 studies

zafirlukast: a leukotriene D4 receptor antagonist

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Holbrook, LM1
Keeton, SJ1
Sasikumar, P1
Nock, S1
Gelzinis, J1
Brunt, E1
Ryan, S1
Pantos, MM1
Verbetsky, CA1
Gibbins, JM1
Kennedy, DR1

Other Studies

1 other study available for ici 204,219 and Blood Clot

ArticleYear
Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.
    British journal of pharmacology, 2021, Volume: 178, Issue:3

    Topics: Animals; Bleeding Time; Blood Platelets; Indoles; Mice; Phenylcarbamates; Sulfhydryl Compounds; Sulf

2021